Javascript must be enabled to continue!
Regional features of the course of demodicosis in dogs
View through CrossRef
Demodicosis is one of the most common diseases in dogs. We have analyzed the epizootological features of the course of demodectic invasion in dogs. In the process of research, territorial, age, breed, sex, seasonal features of the distribution of canine demodicosis, clinical forms of its manifestation were studied. When making a diagnosis, the generally accepted laboratory diagnostic method was used. In the conditions of the Kamenetz-Podolsk region, the share of demodicosis of all pathologies of the skin of dogs is 24.6%. Clinically, 69.9% of the animals had local demodicosis, and its most common forms were scaly (35.4%), mixed (21.2%) and pustular (18.6%). The highest morbidity rate was observed in female short-haired breeds (Bulldog, Rottweiler and Pug) at the age of 7-12 months, there were two peaks in the incidence of dogs in March - 31.1% and in October-November (37.8-34.1%).
Title: Regional features of the course of demodicosis in dogs
Description:
Demodicosis is one of the most common diseases in dogs.
We have analyzed the epizootological features of the course of demodectic invasion in dogs.
In the process of research, territorial, age, breed, sex, seasonal features of the distribution of canine demodicosis, clinical forms of its manifestation were studied.
When making a diagnosis, the generally accepted laboratory diagnostic method was used.
In the conditions of the Kamenetz-Podolsk region, the share of demodicosis of all pathologies of the skin of dogs is 24.
6%.
Clinically, 69.
9% of the animals had local demodicosis, and its most common forms were scaly (35.
4%), mixed (21.
2%) and pustular (18.
6%).
The highest morbidity rate was observed in female short-haired breeds (Bulldog, Rottweiler and Pug) at the age of 7-12 months, there were two peaks in the incidence of dogs in March - 31.
1% and in October-November (37.
8-34.
1%).
Related Results
JIT 2023 - Jornadas de Jóvenes Investigadores Tecnológicos
JIT 2023 - Jornadas de Jóvenes Investigadores Tecnológicos
Es un honor presentar este libro que compila los trabajos de investigación y desarrollo presentados en las Jornadas de Jóvenes Investigadores Tecnológicos (JIT) 2023. Este evento s...
Ivermectin for treatment of generalized demodicosis in dogs
Ivermectin for treatment of generalized demodicosis in dogs
Objective—
To evaluate the efficacy of daily administration of ivermectin in the treatment of dogs with amitraz-resistant generalized demodicosis.
Design—
Prospective, clinical t...
Efficacy of Dipterocarpus alatus oil combination with Rhinacanthus nasutus leaf and Garcinia mangostana pericarps against canine demodicosis
Efficacy of Dipterocarpus alatus oil combination with Rhinacanthus nasutus leaf and Garcinia mangostana pericarps against canine demodicosis
Background and Aim: Canine demodicosis is a skin disease that is a major global health problem in dogs. Ivermectin is a drug of choice for treatment, but it may cause toxicity in d...
Comparison of canine and human immune system response to Demodicosis
Comparison of canine and human immune system response to Demodicosis
One of the types of external human parasites is a follicular scab called
Demodex. Demodicosis is a skin disease in human and canine. Demodex
mites feed on the epithelial cells of t...
The epidemiological and clinical aspects of Demodex injai demodicosis in dogs: a report of eight cases
The epidemiological and clinical aspects of Demodex injai demodicosis in dogs: a report of eight cases
The mite Demodex injai causes demodicosis, an uncommon, chronic, and recurrent parasitic dermatopathy in dogs. Demodicosis is characterized by an excessive proliferation of the Dem...
Treatment options of human demodicosis
Treatment options of human demodicosis
Background: Human demodicosis is a parasitic disease caused by two species of mites, Demodex folliculorum and Demodex brevis. Cutaneous and ocular demodicosis most often occurs in ...
Treatment of canine generalized demodicosis with a ‘spot‐on’ formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate®, Bayer Healthcare)
Treatment of canine generalized demodicosis with a ‘spot‐on’ formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate®, Bayer Healthcare)
AbstractIn this multicentre study, the efficacy of a spot‐on formulation containing 10% imidacloprid and 2.5% moxidectin (Advocate®, Bayer HealthCare) was evaluated for the treatme...
Evaluation of Topical Application of Ronnel Solution for Generalized Demodicosis in Dogs
Evaluation of Topical Application of Ronnel Solution for Generalized Demodicosis in Dogs
SUMMARY
Of 20 dogs with generalized demodicosis, 18 responded favorably to treatment with 8.5% ronnel solution applied to one-third of the body every 3rd day, in rotation. Duration...

